Pardes Biosciences Inc (PRDS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,580 | -17,805 | -96,634 | -72,412 | -49,077 |
| Depreciation Amortization | -2,266 | -1,422 | -1,059 | N/A | N/A |
| Accounts payable and accrued liabilities | -4,915 | -1,214 | 2,779 | -581 | -466 |
| Other Working Capital | -19,334 | -9,644 | 15,157 | 5,055 | 3,980 |
| Other Operating Activity | 8,651 | 3,552 | 7,781 | 8,712 | 5,881 |
| Operating Cash Flow | $-46,444 | $-26,533 | $-71,976 | $-59,226 | $-39,682 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | 85,236 | 13,236 | -138,201 | N/A | N/A |
| Sale Of Investment | 2,190 | 1,177 | 1,180 | N/A | N/A |
| Investing Cash Flow | $87,426 | $14,413 | $-137,021 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 0 | -397 | -397 | -397 |
| Financing Cash Flow | $N/A | $N/A | $-397 | $-397 | $-397 |
| Beginning Cash Position | 59,284 | 59,284 | 268,678 | 268,678 | 268,678 |
| End Cash Position | 100,266 | 47,164 | 59,284 | 209,055 | 228,599 |
| Net Cash Flow | $40,982 | $-12,120 | $-209,394 | $-59,623 | $-40,079 |
| Free Cash Flow | |||||
| Operating Cash Flow | -46,444 | -26,533 | -71,976 | -59,226 | -39,682 |
| Free Cash Flow | -46,444 | -26,533 | -71,976 | -59,226 | -39,682 |